【特约大V】邓声兴:中央周六召开会议,或有利港股稍微反弹

金吾财讯
10 Oct 2024

金吾财讯 | 恒指周三(9日)收报20673点,跌289点或1.38%。大市全日成交4270亿元。国指挫1.6%,报7365;科指则挫1.17%,收4640。《日经新闻》引述消息人士报道,百度(09888)计划在中国境外推出自动驾驶出租车服务ApolloGo,百度下滑0.9%;美团(03690)升2.3%;友邦(01299)走高0.6%。道指周三(9日)收市报42512点,升431点或1.03%;标指上扬0.71%,报5792点;纳指弹0.6%,报18291点,距离7月10日的历史高位低1.9%;美国司法部据报可能历史性寻求把Google拆骨,母企Alphabet收市股价挫1.5%,Meta曾跌1.9%,收市仍挫0.4%,特斯拉反复下滑1.4%;苹果则攀升1.7%。波音公司的信贷评级可能被降至垃圾级别,加上与工会的谈判破裂,股价下滑3.4%,为跌幅最大道指成份股。霍尼韦尔(Honeywell)上扬3.2%,为升幅最大道指成份股,IBM、Nike与Caterpillar都抽高超过2%。亚太股市今早(10日)个别走,日经225指数现时报39442点,升164点或0.42%。南韩综合指数现时报2600点,跌9点或0.37%。中央周六召开会议,或有利港股稍微反弹。市场焦点:长江生命科技(00775)长江生命科技公布,以1亿美元出售从事创新止痛药品的研发、生产及商品化的WEX母公司Pharmagesic(Holdings)Inc.全部股权予在美国纳斯达克上市的VirigosTherapeutics,Virios将发行约21.1万股普通股,占扩大后股本约15.9%股权,以及约2018.4股优先股支付,完成交易后,长江生命科技将间接持有Virios约15.9%已发行普通股,若优先股转换为普通股,持股比例将增至约90.7%。这次WEX与Virios合并是长江生命科技策略性发展里程碑。VIRI拥有痛症领域的研发及商业化经验,透过今次交易,可带来一个新的融资渠道,有利WEX于美国资本市场进行融资及扩大研发团队。目标价$0.63,止蚀价$0.39(笔者为证监会持牌人士及笔者未持有上述股份)

作者:香港股票分析师协会主席邓声兴博士

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10